These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 22287575)

  • 1. Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats.
    Sun Q; Kawamura T; Masutani K; Peng X; Sun Q; Stolz DB; Pribis JP; Billiar TR; Sun X; Bermudez CA; Toyoda Y; Nakao A
    Cardiovasc Res; 2012 Apr; 94(1):144-53. PubMed ID: 22287575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts.
    Nakao A; Huang CS; Stolz DB; Wang Y; Franks JM; Tochigi N; Billiar TR; Toyoda Y; Tzeng E; McCurry KR
    Cardiovasc Res; 2011 Feb; 89(2):457-63. PubMed ID: 20851811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
    Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
    Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
    Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
    EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
    Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen-supplemented drinking water protects cardiac allografts from inflammation-associated deterioration.
    Noda K; Tanaka Y; Shigemura N; Kawamura T; Wang Y; Masutani K; Sun X; Toyoda Y; Bermudez CA; Nakao A
    Transpl Int; 2012 Dec; 25(12):1213-22. PubMed ID: 22891787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant therapy reverses impaired graft healing in hypercholesterolemic rabbits.
    Rosenbaum MA; Miyazaki K; Colles SM; Graham LM
    J Vasc Surg; 2010 Jan; 51(1):184-93. PubMed ID: 19939614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-α/NF-κB pathway.
    Qin ZX; Yu P; Qian DH; Song MB; Tan H; Yu Y; Li W; Wang H; Liu J; Wang Q; Sun XJ; Jiang H; Zhu JK; Lu W; Huang L
    Atherosclerosis; 2012 Feb; 220(2):343-50. PubMed ID: 22153150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do storage solutions protect endothelial function of arterialized vein graft in an experimental rat model?
    Fouquet O; Blossier JD; Dang Van S; Robert P; Barbelivien A; Pinaud F; Binuani P; Eid M; Henrion D; Baufreton C; Loufrani L
    J Cardiothorac Surg; 2020 Feb; 15(1):34. PubMed ID: 32041642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo.
    Muto A; Panitch A; Kim N; Park K; Komalavilas P; Brophy CM; Dardik A
    Vascul Pharmacol; 2012; 56(1-2):47-55. PubMed ID: 22024359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.
    Kallenbach K; Salcher R; Heim A; Karck M; Mignatti P; Haverich A
    J Vasc Surg; 2009 Mar; 49(3):750-8. PubMed ID: 19268777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of vein graft disease using photodynamic therapy with motexafin lutetium in a rodent isograft model.
    Yamaguchi A; Woodburn KW; Hayase M; Robbins RC
    Circulation; 2000 Nov; 102(19 Suppl 3):III275-80. PubMed ID: 11082401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
    Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression and regression of myointimal hyperplasia in experimental vein grafts depends on platelet-derived growth factor and basic fibroblastic growth factor production.
    Sterpetti AV; Cucina A; Lepidi S; Randone B; Stipa F; Aromatario C; Travi D; D'Angelo LS; Cavallaro A; Stipa S
    J Vasc Surg; 1996 Apr; 23(4):568-75. PubMed ID: 8627890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.
    Zhou N; Yu QJ; Si R; Gao HK; Wang T; Gao F; Wang HC; Bian JF
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):402-12. PubMed ID: 20625311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
    Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
    Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia.
    Osgood MJ; Sexton K; Voskresensky I; Hocking K; Song J; Komalavilas P; Brophy C; Cheung-Flynn J
    J Vasc Surg; 2016 Aug; 64(2):471-478. PubMed ID: 27763268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization.
    Ji Y; Adeola O; Strawn TL; Jeong SS; Chen R; Fay WP
    J Thromb Haemost; 2017 Apr; 15(4):814-825. PubMed ID: 28079982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
    Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
    J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.